STOCK TITAN
  1. Home
  2. Financials
  3. RSLS
  4. EPS (Diluted)

ReShape Lifesciences Inc. (RSLS) EPS by Year

RSLS

ReShape Lifesciences Inc. lost $4.86 per diluted share in fiscal year 2025. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters ReShape Lifesciences Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$4.86
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RSLS EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
EPS (Diluted)-$4.86-$6001.39-$110.87-$108.90-$288.97-$5.55N/AN/AN/AN/AN/AN/A

RSLS EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'25Q2'2510-QQ1'2510-QQ4'2410-KQ3'24Q2'2410-QQ1'24Q4'23Q3'23Q2'23
EPS (Diluted)-$0.15N/A-$3.12-$2.25-$761.59N/A-$1419.10-$91.56-$135.37N/A-$59.36-$1.08

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More ReShape Lifesciences Inc. financials

Frequently Asked Questions

What was ReShape Lifesciences Inc.'s diluted earnings per share in fiscal year 2025?

ReShape Lifesciences Inc. lost $4.86 per diluted share in fiscal year 2025.

What was ReShape Lifesciences Inc.'s diluted earnings per share in the most recent quarter?

ReShape Lifesciences Inc. (RSLS) reported -$0.15 in diluted earnings per share in Q1 2026.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what ReShape Lifesciences Inc. (RSLS) reported on that line in every period on record.